Login / Signup

The potential of polygenic scores to improve cost and efficiency of clinical trials.

Akl C FahedAnthony A PhilippakisAmit V Khera
Published in: Nature communications (2022)
Keyphrases
  • clinical trial
  • phase ii
  • human health
  • open label
  • study protocol
  • phase iii